Dr. Jorda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 NW 12th Ave
Suite 4059
Miami, FL 33136Phone+1 305-243-6560
Summary
- Dr. Merce Jorda is the Chair of the Department of Pathology & Laboratory Medicine at the University of Miami, Miami, FL. She is affiliated with multiple hospitals in the area, including Jackson Health System, University of Miami Hospital, and University of Miami Hospital and Clinics. She is a member of the NCI-designated Cancer Center. She received the medical degree from the Autonomous University of Barcelona, PhD from the University of Seville, and MBA in Healthcare Management & Policy from the Herbert Business School University of Miami, Miami, Florida. She been in practice 34 years. She specializes in genitourinary pathology, cytopathology, and breast pathology.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Cytopathology, 1997 - 1998
- University of Miami/Jackson Health SystemResidency, Pathology-Anatomic and Clinical, 1992 - 1996
- Autonomous University of Barcelona Faculty of MedicineClass of 1983
Certifications & Licensure
- FL State Medical License 1996 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12
- Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
- Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
- Join now to see all
Publications & Presentations
PubMed
- Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.Ling Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, Laura Misiara Lincheta, Erin Jackson
Cancer Research. 2025-01-02 - Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacy...Guan-Nan Zhang, Barbara Susnik, Emma J Paulsen, Lisa L Lyons, Katiana S Delma
Archives of Pathology & Laboratory Medicine. 2024-10-01 - Urinary Tract Cytopathology: Current and Future Impact on Patient Care.Merce Jorda, Oleksandr N Kryvenko, Fiona Hanly, Yiqin Zuo
Surgical Pathology Clinics. 2024-09-01
Press Mentions
- Pathology Residency Virtual Open House Is a Big SuccessOctober 8th, 2021
- Teamwork Allows UM Scientists to Answer Call for Increased COVID-19 Student TestingAugust 23rd, 2021
- University Poised to Process 3,000 COVID-19 Tests a DayJanuary 27th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: